Exchange: NASDAQ·Updated 07:30 PM EDT
TLSA logo

TLSA Tiziana Life Sciences Ltd

$1.02
$0.0455
(4.67%)
Today
Closed $1.02
$0.01
(0.98%)
After Hours
Reported EarningsMay 20
Mkt Cap$130.88M
Vol573,921.00

About TLSA

Tiziana Life Sciences Ltd. is a clinical-stage biotechnology company, which engages in developing therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, Amyotrophic Lateral Sclerosis, and Alzheimer’s. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom.
62

Bullish Sentiment

How do you feel about TLSA?

Advertisement|Remove ads.